New patent application

New patent application of anti-cancer drug candidate


After gaining a National Patent entitled “Imidazo-pyrazole carboxamide derivatives as anticancer agents and synthesis”, after PCT submission, Avidin has started on the EU and U.S. patenting process of the anti-cancer drug candidate DU385. The invention relates to novel imidazole [1,2-b]pyrazole carboxamide and carbothioamide derivates, their synthesis, and medicinal applications. These compounds can be advantageously used in the treatment of solid malignancies (including breast, colon, and lung cancers), melanoma, gliomas, and myeloproliferative neoplasms, acute myelogenous/myeloid leukemias.